The Vaccine Production and Quality Control (McV) program will provide accelerated, experiential, and industry-centred training on the fundamentals of vaccine production. Existing and novel vaccine platform technologies will be addressed, including innovative platforms characterized by speed and efficacy, such as nucleic acid-based (DNA/RNA) and recombinant protein-based technologies.

• Type Validation
• Level Intermediate
• Time Weeks
• Cost Paid